UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Series A Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Noncontrolling Interests in Operating Subsidiaries	Treasury Stock, Common
Beginning balance (in shares) at Dec. 31, 2021		350,000
Beginning balance at Dec. 31, 2021		$ 14,753
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value		$ 5,171
Ending balance (in shares) at Dec. 31, 2022	350,000	350,000
Ending balance at Dec. 31, 2022		$ 19,924
Beginning balance (in shares) at Dec. 31, 2021			48,807,748
Beginning balance at Dec. 31, 2021	$ 430,475		$ 49	$ 648,389	$ (181,724)	$ 11,042	$ (47,281)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income including noncontrolling interests in subsidiaries	(110,939)				(125,065)	14,126
Distributions to noncontrolling interests in subsidiaries	(14,126)					(14,126)
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value	(5,171)			(5,171)
Dividend on Series A Redeemable Convertible Preferred Stock	(2,799)			(2,799)
Exercise of warrants (in shares)			5,000,000
Exercise of warrants	20,650		$ 5	20,645
Issuance of common stock for vesting of restricted stock units (in shares)			646,668
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)			197,999
Shares withheld related to net share settlement of share-based awards (in shares)			(372,314)
Shares withheld related to net share settlement of share-based awards	(1,600)			(1,600)
Compensation expense for share-based awards	3,820			3,820
Repurchase of common stock (in shares)			(10,795,234)
Repurchase of common stock	(50,988)		$ (11)				(50,977)
Ending balance (in shares) at Dec. 31, 2022			43,484,867
Ending balance at Dec. 31, 2022	$ 269,322		$ 43	663,284	(306,789)	11,042	(98,258)
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value		$ 3,230
Conversion of Series A Redeemable Convertible Preferred Stock to common stock (in shares)		(350,000)
Conversion of Series A Redeemable Convertible Preferred Stock to common stock		$ (23,154)
Ending balance (in shares) at Dec. 31, 2023	0	0
Ending balance at Dec. 31, 2023		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income including noncontrolling interests in subsidiaries	$ 68,930				67,060	1,870
Distributions to noncontrolling interests in subsidiaries	(1,390)					(1,390)
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value	(3,230)			(3,230)
Dividend on Series A Redeemable Convertible Preferred Stock	(1,400)			(1,400)
Conversion of Series A Redeemable Convertible Preferred Stock to common stock (in shares)			9,616,746
Conversion of Series A Redeemable Convertible Preferred Stock to common stock	36,033		$ 10	36,023
Exercise of warrants (in shares)			31,506,849
Exercise of warrants	129,494		$ 32	129,462
Stock options exercised (in shares)			67,500
Stock options exercised	235			235
Issuance of common stock for vesting of restricted stock units (in shares)			327,684
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)			(34,167)
Shares withheld related to net share settlement of share-based awards (in shares)			(142,759)
Shares withheld related to net share settlement of share-based awards	(614)			(614)
Compensation expense for share-based awards	3,297			3,297
Acquisition of Benchmark	9,821					9,821
Ending balance (in shares) at Dec. 31, 2023			99,895,473
Ending balance at Dec. 31, 2023	$ 589,609		$ 100	$ 906,153	$ (239,729)	$ 21,343	$ (98,258)